20/20 Biolabs, Inc. (AIDX)
0.8669
-0.08
(-8.75%)
USD |
NASDAQ |
May 29, 16:00
0.879
+0.01
(+1.40%)
After-Hours: 20:00
20/20 Biolabs Enterprise Value : 6.110M for May 29, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanara MedTech, Inc. | 243.61M |
| Intelligent Bio Solutions, Inc. | -2.758M |
| Anteris Technologies Global Corp. | 559.58M |
| FONAR Corp. | 91.20M |
| Quest Diagnostics, Inc. | 27.97B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.175M |
| Revenue (Quarterly) | 0.3534M |
| Total Expenses (Quarterly) | 2.528M |
| EPS Diluted (Quarterly) | -0.2031 |
| Gross Profit Margin (Quarterly) | 17.80% |
| Profit Margin (Quarterly) | -615.4% |
| Earnings Yield | -87.47% |